Brief: Biora Therapeutics Q2 EPS from cont ops USD -1.47
14/08/2023 22:03
Aug 14 (Reuters) - Biora Therapeutics Q2 EPS from cont ops USD -1.47. * Q2 net income USD -17.807 million * Q2 pretax profit USD -17.803 million * Q2 revenue USD 2 thousand * Q2 income from operations USD -14.934 million * Q2 basic EPS USD -1.47
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules